PULMONARY DRUG DELIVERY SYSTEMS MARKET ANALYSIS

Market News

Global Pulmonary Drug Delivery Systems Market: Key Developments

On May 3, 2023, Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart, leading manufacturer of drug delivery devices, has entered in a strategic partnership to advance the development of Presspart's Sunriser Capsule-based Dry Powder Inhaler platform. The demand for inhalable drugs that require higher drug loads and the delivery of cohesive materials has increased, making it necessary to develop more efficient solutions. To meet this demand, the two companies will work together to develop the Sunriser Dry Powder Inhaler. This innovative and best-in-class capsule-based platform is flexible enough to address both the challenges of classic carrier-based and spray-dried engineered formulations.

On April 3, 2023, PureIMS, a clinical stage pharmaceutical company, announced it has secured a new investment round by Boost-UP Foundation, a private independent foundations. With the current investments the company also pursues opportunities to further enthuse pharma/biotech companies for early-clinical endeavors looking for innovative pulmonary delivery options to develop small and large molecules for local and systemic indications.

On March 16, 2023, Stevanato Group S.p.A. a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, announced a collaboration with Recipharm, leading Contract Development and Manufacturing Organisation (CDMO). Under the agreement, Stevanato Group will lend its manufacturing experience to support the development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers. As part of this collaboration, Stevanato Group will provide and manufacture its glass pre-fillable syringe Alba assembled with the Integrated Spray Module (ISMTM) of Recipharm’s soft mist inhaler technology, the Pre-Filled Syringe Inhaler (PFSITM).

Global Pulmonary Drug Delivery Systems Market: Key Trends

Increasing acquisition  by the market players

Increasing inorganic growth strategies such as acquisition by the market plaers is expected to drive the growth of the market over the forecast period. For instance, in March 2022, Sandoz, a Novartis AG division, announced that it has successfully acquired Coalesce Product Development Limited., the U.K.-based medical and drug delivery device development company. Through this deal, Sandoz has acquired the significant capabilities and assets of Coalesce, which help it build on its existing portfolio of respiratory medicines and further improve patient access to these high-quality, and complex therapies.